Tag : CV Sciences

Current News Market Watch Uncategorized

CV Sciences, Inc. Sells $13.6 Million Worth of CBD Products in Q3

Editor
CV Sciences, Inc. (OTCQB:CVSI) has announced this morning the company’s Q3 financials for 2018. Their hemp derived Cannbidiol (CBD) product brand +CBD Oil is one of the most popular in the United States. Their brand sells capsules, tinctures, sprays, topicals, gummy’s, and CBD oil in bulk from their website as well...
Cash Crop 150

CCT150 Top Transactions of July

Editor
Aphria Inc. to Expand into Latin America with Proposed $193M Stock Acquisition of LATAM Holdings Aphria Inc. (TSX: APH) (OTC: APHQF) announced this month that the company has entered into a share purchase agreement with private company Scythian Biosciences, Inc. (TSXV: SCYB) (NASDAQ:SCCYF) to acquire 100% of its wholly owned...